YHN Acquisition I Limited (YHNA)

NASDAQ: YHNA · Real-Time Price · USD

10.39

+0.04 (0.39%)

Aug 5, 2025, 4:00 PM - Market closed

Sage Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	1.01	0.29
Operating Expenses	1.01	0.29
Operating Income	-1.01	-0.29
Interest & Investment Income	2.07	0.79
Pretax Income	1.07	0.5
Net Income	1.07	0.5
Net Income to Common	1.07	0.5
Shares Outstanding (Basic)	6	3
Shares Outstanding (Diluted)	6	3
EPS (Basic)	0.17	0.15
EPS (Diluted)	0.17	0.15
EBIT	-1.01	-0.29

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q